July 30, 2012Date Released: 30 July 2012
MESSAGE FROM THE DIRECTOR
Stan Gerson, MD
I serve on the American Society of Hematology (ASH) Investment committee. At our recent meeting we set aside funds from operations and the ASH endowment to support this important initiative. I will also be suggesting to AACR that they consider a similar program. Please consider an application.
ASH Bridge Grant Program
As a demonstration of its commitment to protecting the field and those who have dedicated their careers to the specialty, ASH has pledged $9 million to a new, three-year Bridge Grant Program to help preserve the careers of its talented member scientists whose vital research will not be accomplished due to across-the-board cuts to the NIH budget. Read more about the introduction of the ASH Bridge Grant Program in this ASH press release.
About the Award
• From 2013-2015, ASH will award 90 ASH members (30 per year) with $100,000 bridge grants, for a $9 million total investment.
CASE CCC IN THE NEWS
Removing colon polyps tied to lower cancer risk
Akron Race for the Cure host city for first time
Recent Research: Novel Treatment for Skin Lymphoma
Recent Research: Genetic Cause of Thyroid Cancer Discovered
ANNOUNCEMENTSDr. Mikkael Sekeres Appointed FDA Committee Chair
Dr. Mikkael Sekeres is the new Chair of the Oncologic Drugs Advisory Committee of theFood and Drug Administration (FDA). The Committee reviews and evaluates data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of cancer and makes appropriate recommendations to the Commissioner of Food and Drugs. Dr. Sekeres has been a voting member of this Committee for the past three years.Registration of Clinical Trials in Clinicaltrials.Gov
As required by the International Committee of Medical Journal Editors (ICMJE), any intervention type of clinical trial (drugs, biologics, devices, surgical, behavioral or other) must be registered in clinicaltrials.gov PRIOR to registration of the first patient. Editors of the ICMJE will not consider publication of manuscripts if trials are not registered completely and prospectively.
In order for the Case CCC to provide this service, studies in the OnCoreTM database must be updated in real time. If you need any assistance, please contact April Firstencel email@example.com or call 216.286.2294.
FUNDING OPPORTUNITIESDOD Broad Agency Announcement for Extramural Biomedical Research and Development
The United States Special Operations Command (USSOCOM)seeks novel biomedical solutions to preserve the high level of performance and save the lives of Special Operations Forces (SOF) in field environments. Any projects proposed must be unique to the requirements of SOF who typically conduct combat operations in austere, remote locations without timely access to medical evacuation or elevated levels of medical care. It is these far-forward and/or isolated operations that make SOF medicine unique and result in material solutions characterized by ruggedness, light weight, small volume, and low power requirements. USSOCOM is also interested in research that will lead to improved techniques and procedures that do not necessarily require new material.
Pre-proposal Deadline: August 3
The Damon Runyon Cancer Research Foundation is accepting applications for the Fellowship Award. The Foundation encourages all theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies and prevention. Candidates must apply for the fellowship under the guidance of a Sponsor capable of providing mentorship to the Fellow.
Deadline: August 15Leukemia & Lymphoma Society Career Development Program
The Leukemia & Lymphoma Society (LLS) Career Development Program (CDP) offers career development awards to researchers in various stages of their research careers.
LOI Deadline for all awards: September 15 3 pm ET
NCI CANCER BULLETINSpecial Issue: Oncology Nursing (July 24, 2012)
**All events are open to anyone interested in attending
Pharmacology Student Invited Seminar
Hematology and Oncology Division Research Conference
Molecular Biology and Microbiology Seminar
Cancer Center Faculty Candidate
Imaging and Cytometry Seminar
Molecular Biology and Microbiology Seminar
Cancer Center Research in Progress will resume in September
Cancer Center Seminar Series will resume in September.
Taussig Cancer Institute Grand Rounds will resume in September
Hematology/Oncology Fellows Conference/Curriculum Series
Case CCC Calendar
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS
Developmental Therapeutics Program Retreat: Cancer Drug Development at the Case Comprehensive Cancer Center
Second Annual Imaging Solutions in Cancer Management: A Case-Based Conference
National GvHD Health Symposium
ADDITIONAL UPCOMING SEMINARS & EVENTS
Ninth International Conference of the Society for Integrative Oncology
Biennial Science of Global Prostate Cancer Disparities conference
Pacific Symposium on Biocomputing 2013
PREVIOUSLY ANNOUNCED OPPORTUNITIES
Alex's Lemonade Stand Foundation Bridge Grant
Oncology Nursing Society Foundation Advancing Care through Science Conference Scholarship
NIH BULLETIN – Notices and Funding Opportunities
Tobacco Centers of Regulatory Science for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (P50) (RFA-DA-13-003)
Physical activity and weight control interventions among cancer survivors: Effects on biomarkers of prognosis and survival (R01) (PAR-12-228)
Physical activity and weight control interventions among cancer survivors: Effects on biomarkers of prognosis and survival (R21) (PAR-12-229)
Prioritizing Molecular Targets for Cancer Prevention with Nutritional Combinations (R01)(PA-10-035)
Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R01)(PA-10-025)
Epigenetic Approaches in Cancer Epidemiology (R01)(PA-10-031)
Epigenetic Approaches in Cancer Epidemiology (R21)(PA-10-032)
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!
Send items to firstname.lastname@example.org.